about
Parkinson's disease: from monogenic forms to genetic susceptibility factorsDrosophila HtrA2 is dispensable for apoptosis but acts downstream of PINK1 independently from ParkinTARDBP mutations in Parkinson's disease.Novel mitochondrial substrates of omi indicate a new regulatory role in neurodegenerative disorders.Modulation of mitochondrial function and morphology by interaction of Omi/HtrA2 with the mitochondrial fusion factor OPA1.Neural-specific deletion of Htra2 causes cerebellar neurodegeneration and defective processing of mitochondrial OPA1.VPS35 mutations in Parkinson diseaseAltered enzymatic activity and allele frequency of OMI/HTRA2 in Alzheimer's diseaseGeneration and characterization of mice with a conditional null allele of the HtrA4 gene.A large-scale genetic association study to evaluate the contribution of Omi/HtrA2 (PARK13) to Parkinson's disease.Drosophila as a model to study mitochondrial dysfunction in Parkinson's disease.Loss-of-function analysis suggests that Omi/HtrA2 is not an essential component of the PINK1/PARKIN pathway in vivoMitochondrial dynamics in Parkinson's disease.Genetics of Parkinson disease and essential tremorMutation Analysis of HTRA2 Gene in Chinese Familial Essential Tremor and Familial Parkinson's Disease.Mitochondrial proteomics as a selective tool for unraveling Parkinson's disease pathogenesis.LINGO1 variants in essential tremor and Parkinson's disease.Mitochondrial quality control: a matter of life and death for neurons.Mitochondrial Quality Control Proteases in Neuronal Welfare.HTRA2 p.G399S in Parkinson disease, essential tremor, and tremulous cervical dystoniaHTRA2 variations in Taiwanese Parkinson's disease.
P2860
Q22242870-818E0ACA-0615-45B1-AE44-75D2A0020EBDQ28752238-2E949742-65D0-4603-8D64-E45EADE6A2AFQ30536779-55B0EAA2-A844-40C3-B6AA-64E8E274BBC9Q33504585-B823FF60-36DB-4904-8DC7-59B51E896701Q34713631-8E59001E-AEBB-496D-A7DF-6496760DDE13Q34758274-8D3D5BFF-8B10-4157-BB71-50B99BF3CC72Q35103751-70B00955-F131-4BFA-8699-9EB9AD6BB8A7Q35585384-B842F7F7-0019-418D-9677-F32DC016AAC4Q36224858-B9285535-663D-4F05-B55B-C8A7505C4296Q36494703-D87F5FCA-232B-4FF1-B763-0819C3090BFAQ36526622-FC654659-50D8-44D1-94B5-A2A428AF5278Q37281615-4AB987E1-4BA4-40D7-9E1C-45E5986DA4A9Q37364337-CFA54363-5F37-490D-8E44-59FFF28582EEQ37594762-6E3C7BA5-0210-4E06-A6D3-BE513B12CC92Q37627534-EDBC3366-505D-4A17-ACF9-7B064D63CED2Q37727186-5CE190BC-6F3A-4E96-B7D2-E4593B6F22AAQ37862352-A61F7306-160A-49B5-A7CF-5DE5356E7808Q37987023-73A5CC37-E1C6-4E1C-BEDF-F8D3A3A638D3Q38823556-01273739-2F03-46C4-A46B-DB9DF79B4065Q42562233-8B392C8A-9E0A-4829-90ED-203DD6D3A312Q54441120-879A8773-CCF3-4765-9697-892ACEF0A25E
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 14 September 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Genetic variation of Omi/HtrA2 and Parkinson's disease
@en
Genetic variation of Omi/HtrA2 and Parkinson's disease.
@nl
type
label
Genetic variation of Omi/HtrA2 and Parkinson's disease
@en
Genetic variation of Omi/HtrA2 and Parkinson's disease.
@nl
prefLabel
Genetic variation of Omi/HtrA2 and Parkinson's disease
@en
Genetic variation of Omi/HtrA2 and Parkinson's disease.
@nl
P2093
P2860
P50
P1476
Genetic variation of Omi/HtrA2 and Parkinson's disease
@en
P2093
Alexandra I Soto
Anna Krygowska-Wajs
Grzegorz Opala
J Mark Gibson
Jan O Aasly
Krzysztof Czyzewski
Maria Barcikowska
Mary M Hulihan
Matthew J Farrer
Michael G Heckman
P2860
P304
P356
10.1016/J.PARKRELDIS.2008.08.003
P577
2008-09-14T00:00:00Z